# Hikma Pharmaceuticals USA, Inc. – FDA Inspection, Feb 1, 2019

Source: https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/3defe1cf-0b52-4315-8126-2a19c7870047
Source feed: FDA_Inspections

> FDA inspection 1079961 of Hikma Pharmaceuticals USA, Inc., February 01, 2019. Classification: No Action Indicated (NAI). 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079961
- Company Name: Hikma Pharmaceuticals USA, Inc.
- Inspection Date: 2019-02-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1054739 - 2018-04-13
- [FDA Inspection 976090 - 2016-07-07](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/a39d289b-eef3-401a-b2ac-d25f0be87c2b)
- [FDA Inspection 942928 - 2015-09-10](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/fd7a26ee-8e04-40a8-a48f-049c42425762)
- [FDA Inspection 864847 - 2014-02-26](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/43cf47d1-bde3-4a28-8f72-4cfd10f40264)
- [FDA Inspection 829253 - 2013-06-07](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/48dd1a6a-58ea-452a-a2fb-908ad3ebbe94)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-r-lenahan/c695dac2-5447-434b-801e-f95e6acf05f1)

Company: https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/f0f0db3f-c818-4402-a2c9-858a3171c8b2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
